1/24
Lecture idk actually
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Drugs
Chemical substances which interact with the biochemistry of the body:
Inhibit or reinforce enzyme activity
Block or activate receptors
Interact with neurotransmitters or hormones in other ways
Attack “invaders” (e.g. antibiotics)
What are psycho-active drugs?
Any chemicals that influence the way we feel or act
Usually they interact with the nervous system and/ or the endocrine system
Mostly, they act at synapses (among other places)
Agonist vs. Antagonist
At the synapse level (effect on post-synaptic cell):
Agonist; mimics action of the neurotransmitter
Antagonist; blocks action of the neurotransmitter
At the receptor level (effect on receptor):
Agonist; mimics action of the neurotransmitter
Antagonist; blocks action of the neurotransmitter
Possible sites of drug action
If a drug is an antagonist on the presynaptic receptors - it results in an increase in neurotransmitter - makes it an agonist at the synaptic level
If its agonist at the receptor level (stimulates the receptors prevents release of neurotransmitter) - it will be antagonist at the synaptic level as it prevents the release of neurotransmitters
Pharmacokinetics: Intake
Many routes:
Digestive tract
Respiratory tract
Through skin
Through mucous membranes
Intravenous injection (directly into the blood)
Intramuscular injection (into the muscles)
Subcutaneous injection (under the skin)
What is the slowest uptake route?
Digestive Tract
Pharmacokinetics: Distribution
Bloodstream goes all across the body
Water-soluble molecules can be directly dissolved in the blood, but do not pass through cell membranes
LIpid-soluble molecules need carriers to transport them through blood, but can pass directly through cell membranes
Blood-Brain Barrier
Around most of the body the capillaries have gaps that permit the free flow of substances into and out of the blood
In the brain, these capillaries do not have these gaps, preventing these substances from entering - unless the toxin or drug is fat soluble, as their membrane is made of fat (phospholipid bilayer), allowing entry into the brain - despite their difficulty in transporting in the blood
In order to be psychedelic it almost has to be fat soluble
Pharmacokinetics: Elimination
All drugs are eventually eliminated from the body:
By chemical break down (by enzymes)
By excretion (in urine)
Some drugs can be stored in the body for a long time (e.g. lipid-soluble drugs in fat tissue)
Biological Half-Life can vary from minutes to weeks
Biological Half-Life
The time it takes for the drug to go from peak concentration to half concentration
Shorter Half-Life means it can get to half quicker
Longer means it takes longer to get to half
Typically, more lipophilic drugs have…
Longer Half-Life than less lipophilic drugs
Physical Dependence: Drug Tolerance
In tolerant subjects, a greater dose is required to produce the same effect
Body maintains homeostasis
Mechanisms:
Metabolic tolerance (better elimination of the drug)
Functional tolerance:
Change in receptor numbers
Change in receptor sensitivity
Change in intra-cellular cascades
Tolerance leads to withdrawal effects - the tolerance mechanisms are still there if the drug goes away
Opposite effects of the drug = withdrawal effects
Results in physical dependence on the drug - they now take the drug to prevent the withdrawal effects
Tolerance is Context Dependent
Overdosing is easier in novel surroundings
Withdrawal symptoms also occur in familiar settings - context (like your house) can trigger withdrawal symptoms
Possibly a reason for relapsing
“Psychological” Drug Dependence - Operant Conditioning
Stimulus results in increase in behaviour based on a reinforcement system
Intra-Cranial Self-Stimulation
An operant Chamber with a lever, used in studying the effects of reinforcing brain stimulation
Rats activate lever, which activates the reinforcement part of their brain, which results in an increase in the behaviour
Major Brain Subdivisions
Forebrain
Telencephalon
Diencephalon
Midbrain
Mesencephalon
Hindbrain
Metencephalon
Myelencephalon
Mesotelencephalic Dopamine System (?)
Ventral tegmental area
Nucleus accumbens
Involvement of Dopamine in reward
Dopamine levels increase in the Nucleus Accumbens
How do you test whether dopamine release is causally involved in the rewarding effect of intracranial stimulation?
Block the action of dopamine whilst stimulating
Reward: Pleasure or…..?
Dopamine is released with punishing stimuli as well
Overtrained rats do not release dopamine upon reward
Dopamine blockers make rats work less hard for food, but they still enjoy it
Dopamine doesn’t seem to be related to pleasure
Alternate hypothesis: SEEKING or WANTING
Dopamine release is not the cause of enjoying something
If you increase dopamine animals will start exploring more
It also drives animals to repeat something, even if that thing is not pleasurable
“Psychological” Dependence
When drugs directly interact with the brain’s reward system
Addit will crave drugs, even while disliking their effects
Cocaine increases Dopamine levels
Cocaine and Amphetamines increase the amount of dopamine even when directly injected into the Nucleus Accumbens
Intracranial Drug Self-Administration
The rat has a catheter(?) - (like a lil needle thing) injected into it and it pesses the lever to self-inject the drug, from an infusion pump, either in a particular area of the brain or into general circulation
Summary
Different Drugs have different pharmacokinetics
Physical drug dependence is due to drug tolerance
The Ventral Tegmental Area and Nucleus Accumbens are involved in the “reward” or “seeking” system in the brain
Psychological dependence works through this Mesotelencephalic dopamine pathway